The addition of inosine, a purine nucleoside, to acid-citrate-dextrose (ACD) solution has been proposed as a means for prolonging the storage period of blood used for transfusion purposes (1). Inosine appears to affect the carbohydrate and phosphate metabolism of the erythrocyte and thereby improve the viability of stored red cells (1).
The addition of inosine, a purine nucleoside, to acid-citrate-dextrose (ACD) solution has been proposed as a means for prolonging the storage period of blood used for transfusion purposes (1) . Inosine appears to affect the carbohydrate and phosphate metabolism of the erythrocyte and thereby improve the viability of stored red cells (1) .
Since an increase in the outdating period of blood would be of great value, this study was undertaken by four different laboratories in order to compare standard acid-citrate-dextrose and acid-citrate-dextrose-inosine (ACDI) as blood preservatives. In 109 studies the comparison of ACD and ACDI was made by biochemical and hematologic tests done in vitro and the survival of transfused Cr51-tagged red cells measured in vivo.
This report is a compilation of the results obtained in all four laboratories.
METHODS
For each study approximately 450 ml. of blood was collected from healthy human volunteers in either ACD or ACDI solution. If less than 450 ml. of blood was collected this is indicated in the tables and figures. Both preservative solutions contained 67.5 ml. ACD, NIH Formula A. For the ACDI solution, 1.8 Gm. of inosine 3 was added to the ACD solution before autoclaving. In 15 studies two different inosine preparations 4 were tested and Seitz filtration was used as the method of sterilization. Three types of containers were purchased. Glass bottles were supplied by Baxter Laboratories. Type F plastic packs with attached donor set were supplied by the Fenwall Laboratories. Type C plastic packs without an attached donor set were supplied by the Cutter Laboratories.
Following collection, the blood was stored at 4°C. for periods of 20 to 43 days. After various time intervals of in vitro storage, portions of the blood were tagged with Cr'1 and transfused to the original donor or to appropriate recipients. The methods of Cr' tagging have been previously described (2) (3) (4) (5) . From 30 to 87.3 ftc. of Cr' was used with specific activities of from 0.90 to 1.752 mc. per mg. The survival rate was determined. The method for estimating the recipient's red cell volume differed in each laboratory. Dr. Strumia's group estimated the blood volume by the Evans blue dye method (2) . Dr. Gibson's and Dr. Finch's groups used P'1 by methods already published by each independently (3, 4) . Dr. Crosby's group used radioiodinated serum albumin (RISA®) (5) . The method for estimating the red cell volume did not appear to affect the results and for the purpose of presentation the survival results from each group were averaged. The apparent half-time survival of the red cells (T/2) was calculated where possible.
In four studies, after 21 or 28 day storage periods, a sample was removed for tests in vivo and in vitro and the blood was immediately returned to the refrigerator. Following a further two week storage period, the same tests were repeated on the same blood and in the same subject. For these studies, one-half of the usual amount of Cr' was used for each in vivo study.
In four studies an entire unit of whole blood was transfused. The Cr' was added directly to the entire unit of blood. During the transfusion the pulse and blood pressure were measured every five minutes. The uric acid content of 24 hour urine samples was measured in two instances.
In 39 of the studies, in vitro tests were performed on the day of collection and again on the day of transfusion. These included determinations of: 1) mean corpuscular hemoglobin concentration (MCHC), 2) plasma Na, 3) (6) . Adenosine-triphosphate was determined by a method which was an adaption of the procedures described by Fiske and Subbarow (7), Hawk, Oser and Summerson (8), Gomori (9) and Lohmann (10). The remaining in vitro studies were done by standard methods. Before transfusion, Gram-stained smears were examined for bacterial contamination. None was found.
RESULTS
The results of the studies in vivo and in vitro are summarized in Tables I and II. Except for an elevated plasma hemoglobin in units collected by vacuum in glass bottles, both initially and on storage, there were no significant differences between the different types of containers. A fall in plasma Na concentration occurred during storage. Concurrently there was an increase in the plasma K. The plasma hemoglobin also increased and an increasing percentage of red cells were hemolyzed in 0.63 per cent NaCl. Variable results were obtained in the measurement of pH, lactic acid and dextrose. However, there was an increase in lactic acid content and a trend toward decreases in both pH and dextrose on storage. In 35 of 45 determinations the MCHC increased on storage indicating the loss of some water. Inosine did not retard these in vitro changes. However, when adenosine triphosphate (ATP) levels were measured, the blood preserved in inosine showed a higher amount of ATP than control bags not containing inosine (Table II) . Where duplicate studies were performed, the decreased 24 hour survival is readily apparent (Figure 2) . The type of container in which the blood was stored did not affect these results.
In general, the viable cells survived well; however, the T/2 decreased as the length of storage increased (Tables I and II (Tables I and II) . The pulse and blood pressure were not affected by the transfusion. In two instances, the uric acid in a 24 hour collection of urine following the transfusion was found to be 1,072 and 1,940 mg. (normal values, up to 1,000 mg.).
The in vitro survival of red cells stored in two different inosine preparations 6 sterilized by Seitz filtration was studied. The results are summarized 6 One preparation obtained from Zellstoff WaldhofWerke, Mannheim, Germany; one preparation obtained from Schwartz laboratories.
in Table III . With few exceptions the inosine employed was unable to effect satisfactory survival at either 36 or 42 days.
It was noted that in some of the specimens of blood stored with the addition of inosine, a rather heavy white precipitate appeared. Samples of this precipitate were tested by Dr. David R. Schwartz and found probably to consist of hypoxanthine. The hypoxanthine content was determined by direct ultraviolet measurement of the precipitate and confirmed by chromatography and spectrophotometric assay of the only ultraviolet absorping spot which appeared on the developed chromatogram.
DISCUSSION
The action of added inosine in blood preservation has recently been discussed by Gabrio, Donohue, Huennekens and Finch (1) and will not be dealt with in this report.
Gabrio and associates found the average survival of three units of blood studied by both Cr51 and Ashby techniques to be 82 per cent after in vitro storage of five and six weeks in ACDI. While similar results were obtained in 19 per cent of the studies reported here, there were, in general, poor survival results when the storage period was lengthened beyond 28 days. However, inosine did appear able to prolong the storage period for at least seven days.
There were certain technical differences between Gabrio's original study and the studies reported here. In the original study 120 ml. of ACD, NIH Formula B, was used. In the present study 67.5 ml. of ACD, NIH Formula A, was used. Formula B is composed of: trisodium citrate, 1.32 Gm.; citric acid, 0.48 Gm.; dextrose, 1.47 Gm.; with sufficient water to make 100 ml. Formula A is composed of: trisodium citrate, 2.2 Gm.; citric acid, 0.8 Gm.; dextrose, 2.45 Gm.; and sufficient water to make 100 ml. Both ACD solutions have been found to give adequate blood preservation for 21 days. With the addition of inosine, however, the effect of the different ACD preservatives used is unknown. In the original study the preservative was sterilized by scintered glass filtration and the inosine was added to the blood within 24 hours after it had been drawn into ACD. In the present study the inosine was added to the ACD and the preservative autoclaved. The 
